Skip to main content

Table 3 Association between TyG-BMI and CVD/all-cause mortality

From: Triglyceride glucose-body mass index and cardiovascular mortality in patients undergoing peritoneal dialysis: a retrospective cohort study

 

Model 1

Model 2

Model 3

 HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

CVD mortality

TyG-BMI (per SD increase )

1.38 (1.24–1.53)

< 0.001*

1.24 (1.10–1.39)

< 0.001*

1.28 (1.13–1.45)

< 0.001*

Quartile 2

1.47 (1.03–2.10)

0.036*

0.97 (0.68–1.40)

0.883

0.93 (0.62–1.37)

0.700

Quartile 3

1.40 (0.98–2.00)

0.068

0.83 (0.58–1.20)

0.323

0.80 (0.54–1.20)

0.280

Quartile 4

2.46 (1.77–3.42)

< 0.001*

1.50 (1.08–2.10)

0.016*

1.51 (1.05–2.17)

0.027*

All-cause mortality

TyG-BMI (per SD increase )

1.28 (1.19–1.38)

< 0.001*

1.21 (1.03–1.22)

0.008*

1.19 (1.09–1.31)

< 0.001*

Quartile 2

1.32 (1.04–1.69)

0.023*

0.92 (0.72–1.18)

0.501

0.91 (0.69–1.19)

0.487

Quartile 3

1.42 (1.12–1.80)

0.004*

0.85 (0.67–1.08)

0.194

0.91 (0.70–1.19)

0.503

Quartile 4

2.00 (1.59–2.51)

< 0.001*

1.23 (0.98–1.55)

0.080

1.36 (1.05–1.75)

0.018*

  1. HR, hazard ratio
  2. CI, confidence interval
  3. SD, standard deviation
  4. Reference group was Quartile 1
  5. Model 1: Unadjusted
  6. Model 2: Adjusted for age, sex, systolic pressure, and history of CVD
  7. Model 3: Adjusted for model 2 covariates and hemoglobin, serum albumin, LDL-C, urine output and use of lipid-lowering agents
  8. *P < 0.05